ATE311463T1 - Fusionsprotein mit multiplen epitopen - Google Patents

Fusionsprotein mit multiplen epitopen

Info

Publication number
ATE311463T1
ATE311463T1 AT97927767T AT97927767T ATE311463T1 AT E311463 T1 ATE311463 T1 AT E311463T1 AT 97927767 T AT97927767 T AT 97927767T AT 97927767 T AT97927767 T AT 97927767T AT E311463 T1 ATE311463 T1 AT E311463T1
Authority
AT
Austria
Prior art keywords
epitopes
epitope
amino acid
acid sequence
sequences
Prior art date
Application number
AT97927767T
Other languages
German (de)
English (en)
Inventor
Pablo D T Valenzuela
David Ying Chien
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/653,226 external-priority patent/US6514731B1/en
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE311463T1 publication Critical patent/ATE311463T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT97927767T 1996-05-24 1997-05-23 Fusionsprotein mit multiplen epitopen ATE311463T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/653,226 US6514731B1 (en) 1996-05-24 1996-05-24 Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
US08/859,524 US6428792B1 (en) 1996-05-24 1997-05-20 Hepatitis C virus multiple copy epitope fusion antigens
PCT/US1997/008950 WO1997044469A2 (en) 1996-05-24 1997-05-23 Multiple epitope fusion protein

Publications (1)

Publication Number Publication Date
ATE311463T1 true ATE311463T1 (de) 2005-12-15

Family

ID=27096474

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97927767T ATE311463T1 (de) 1996-05-24 1997-05-23 Fusionsprotein mit multiplen epitopen

Country Status (11)

Country Link
EP (1) EP0935662B1 (enExample)
JP (2) JP3945822B2 (enExample)
AT (1) ATE311463T1 (enExample)
AU (1) AU719929B2 (enExample)
CA (1) CA2250723C (enExample)
DE (1) DE69734776T2 (enExample)
DK (1) DK0935662T3 (enExample)
ES (1) ES2251028T3 (enExample)
IL (1) IL126460A (enExample)
NZ (1) NZ333431A (enExample)
WO (1) WO1997044469A2 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6322965B1 (en) * 1997-02-10 2001-11-27 Advanced Life Science Institute, Inc. Chimera antigen peptide
CA2303123C (en) 1997-09-22 2006-04-11 Chiron Corporation Method for detecting antibodies in a sample
CA2303165C (en) 1997-09-22 2006-07-11 Chiron Corporation Buffers for stabilizing antigens
EP1056762A4 (en) * 1998-01-30 2003-07-23 Gen Hospital Corp GENETIC IMMUNIZATION WITH HEPATITIS C VIRUS NON-STRUCTURAL PROTEINS
AU751362B2 (en) 1998-04-17 2002-08-15 Innogenetics N.V. Improved immunodiagnostic assays using reducing agents
WO1999058561A1 (fr) * 1998-05-14 1999-11-18 Pasteur Merieux Serums & Vaccins Mimotopes du virus de l'hepatite c
US7052696B2 (en) * 1998-07-10 2006-05-30 The United States Of America As Represented By The Department Of Health And Human Services Antigenic epitopes and mosaic polypeptides of hepatitis C virus proteins
US6379903B1 (en) * 1999-10-08 2002-04-30 Sigma-Aldrich Co. Purification of recombinant proteins fused to multiple epitopes
ES2411096T3 (es) 1999-10-27 2013-07-04 Novartis Vaccines And Diagnostics, Inc. Activación de linfocitos T específicos contra el VHC
AU780064B2 (en) * 1999-12-28 2005-02-24 Epimmune, Inc. Optimized minigenes and peptides encoded thereby
US7491808B2 (en) 2000-06-15 2009-02-17 Novartis Vaccines And Diagnostics, Inc. HCV non-structural protein mutants and uses thereof
BRPI0111731C1 (pt) * 2000-06-15 2021-07-27 Chiron Corp suporte sólido de imunoensaio, métodos de detecção de infecção pelo vírus da hepatite c (hcv) em uma amostra biológica, e de produção de um suporte sólido de imunoensaio, e, kit de teste de imunodiagnóstico
EP1829891B1 (en) 2000-06-15 2012-12-26 Novartis Vaccines and Diagnostics, Inc. Immunoassays for Anti-HCV Antibodies
WO2003008537A2 (en) * 2001-04-06 2003-01-30 Mannkind Corporation Epitope sequences
AR045702A1 (es) 2001-10-03 2005-11-09 Chiron Corp Composiciones de adyuvantes.
ES2312806T3 (es) 2002-09-09 2009-03-01 Novartis Vaccines And Diagnostics, Inc. Ensayo de vhc.
EP1576125A4 (en) * 2002-10-25 2008-09-03 Novartis Vaccines & Diagnostic ACTIVATION OF SPECIFIC HCV LYMPHOCYTES
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
EP1799868B1 (en) 2004-08-27 2012-01-18 Novartis Vaccines and Diagnostics, Inc. Hcv non-structural protein mutants and uses thereof
CA2610919C (en) * 2005-06-17 2013-09-10 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Hepatitis c virus nucleic acid vaccine
WO2007081447A2 (en) 2005-11-22 2007-07-19 Novartis Vaccines And Diagnostics, Inc. Norovirus and sapovirus antigens
AU2008335457B2 (en) 2007-12-07 2015-04-16 Glaxosmithkline Biologicals S.A. Compositions for inducing immune responses
JP6069212B2 (ja) 2010-12-02 2017-02-01 ビオノール イミュノ エーエスＢｉｏｎｏｒ Ｉｍｍｕｎｏ Ａｓ ペプチド骨格設計
JP6294076B2 (ja) 2011-01-06 2018-03-14 ビオノール イミュノ エーエスＢｉｏｎｏｒ Ｉｍｍｕｎｏ Ａｓ 多量体ペプチド
CA3207612A1 (en) * 2012-01-26 2013-08-01 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
WO2013182661A1 (en) 2012-06-06 2013-12-12 Bionor Immuno As Peptides derived from viral proteins for use as immunogens and dosage reactants
IL282614B2 (en) 2015-02-06 2024-02-01 Cell Idx Inc Antigen-conjugated immune reagents
ES2832335T3 (es) 2015-03-27 2021-06-10 Ortho Clinical Diagnostics Inc Polipéptidos NS4A/NS3 modificado del VHC y usos de los mismos
WO2018017606A1 (en) * 2016-07-18 2018-01-25 Cell Idx, Inc. Antigen-coupled hybridization reagents
KR101813586B1 (ko) * 2016-12-29 2018-01-30 고려대학교 산학협력단 다양한 질병마커 인지 에피토프와 연결된 단백질 나노입자 및 이를 이용한 고민감도 질병마커 검출방법
JP7389740B2 (ja) * 2017-07-27 2023-11-30 エフ． ホフマン－ラ ロシュ アーゲー Ｈｃｖ抗原のマルチエピトープ融合タンパク質およびその使用
KR101871985B1 (ko) * 2017-08-14 2018-06-27 고려대학교 산학협력단 3차원 단백질 나노입자 프로브 기반 복수 질환의 동시검출 방법 및 키트
CN108794636B (zh) * 2018-06-28 2020-05-22 中国人民解放军军事科学院军事医学研究院 一种表位多肽串联混合物在抗立氏立克次体的免疫保护中的应用
KR102100813B1 (ko) * 2018-11-08 2020-04-16 주식회사 보레다바이오텍 C형 간염바이러스 유래 융합 단백질 및 이를 포함하는 진단키트
CA3224156A1 (en) 2021-06-28 2023-01-05 VST LLC dba Medgene Labs Sapovirus vaccines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0185426B1 (ko) * 1991-06-24 1999-04-01 로버트 피. 블랙버언 씨형 간염 바이러스 폴리펩티드
IL103456A (en) * 1991-10-16 2006-06-11 Merck Patent Gmbh Isolated peptides having t-cell stimulating activity
US5683695A (en) * 1993-02-10 1997-11-04 United Biomedical, Inc. Production of recombinant proteins containing multiple antigenic determinants linked by flexible hinge domains
US5744144A (en) * 1993-07-30 1998-04-28 University Of Pittsburgh University Patent Committee Policy And Procedures Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
GB2294047A (en) * 1994-10-14 1996-04-17 Merck & Co Inc Synthetic peptides for use as epitopes specific for HIV

Also Published As

Publication number Publication date
DE69734776T2 (de) 2006-08-17
DK0935662T3 (da) 2006-03-06
AU719929B2 (en) 2000-05-18
CA2250723C (en) 2012-07-17
JP2007127671A (ja) 2007-05-24
DE69734776D1 (de) 2006-02-09
WO1997044469A2 (en) 1997-11-27
JP2001500723A (ja) 2001-01-23
EP0935662A2 (en) 1999-08-18
AU3214397A (en) 1997-12-09
NZ333431A (en) 2000-05-26
IL126460A (en) 2007-07-04
ES2251028T3 (es) 2006-04-16
JP3945822B2 (ja) 2007-07-18
WO1997044469A8 (en) 1999-07-22
CA2250723A1 (en) 1997-11-27
EP0935662B1 (en) 2005-11-30
WO1997044469A3 (en) 1997-12-31
IL126460A0 (en) 1999-08-17

Similar Documents

Publication Publication Date Title
DE69734776D1 (de) Fusionsprotein mit multiplen Epitopen
HUP0100094A1 (hu) Új felületi antigén
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
DK2230299T3 (da) Hidtil ukendt cytokin ZCYTOR17-ligand
Priest et al. Detection by enzyme immunoassay of serum immunoglobulin G antibodies that recognize specific Cryptosporidium parvum antigens
EP0739980A3 (en) CD 19 coding DNA
KR20150095691A (ko) 단일 분자 검출을 이용한 분자 분석물질의 디지털 분석
DE69738749D1 (de) Zelloberflächen-antigen aus säugetieren und verwandte reagenzien
DK296189A (da) Nucleinsyresekvenser, som koder for peptidsekvenser af carcinoembryonisk antigen-familien
CA2453528A1 (en) Novel fusion proteins and assays for molecular binding
NO315163B1 (no) Immunologisk aktive peptider, DNA-sekvenser som koder for peptidene og anvendelse av disse i et testsett for påvisning av virus somforårsaker immunsvikt
DE69738811D1 (de) Oberflächenantigene aus Säugern
NO970740L (no) Glutamat reseptor
CA2192940A1 (en) Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections
ATE162550T1 (de) Ospc-antigen-impfstoffe immunogene zusammensetzung zur vorbeugung und behandlung von lyme-krankheit und rekombinante verfahren zur herstellung von derartige antigene
WO1999009179A3 (en) Antigen constructs useful in the detection and differentiation of antibodies to hiv
Sledge et al. Antibody structure: amino terminal sequences of nurse shark light and heavy chains
DK0580672T3 (da) Syntetisk CDw52-(CAMPATH-1)-peptidantigen
CA2239753A1 (en) Novel semaphorin z and gene encoding the same
DK0773999T3 (da) OR-1, en orphan-receptor tilhørende kernereceptorfamilien
DE3569161D1 (en) Process for assaying atl virus antibody and reagent therefore
CA2262500A1 (en) Measles virus mutant antigen and gene coding for the same
SU676303A1 (ru) Способ разделени углеводородных газов
ATE384738T1 (de) Chlamydia antigene, entsprechende dna fragmente und ihre verwendungen
TH45960A (th) วัคซีนต่อต้านโรคพิษสุนัขบ้าที่ไม่ทำให้เกิดโรค

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0935662

Country of ref document: EP